CAI Q1 2025 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

CAICaris Life Sciences, Inc.

$5B

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$121M+49.9% YoY

Gross Profit

$57M47.2% margin

Operating Income

-$58M-47.9% margin

Net Income

-$103M-84.8% margin

EPS (Diluted)

$-0.40

Cash Flow

Operating Cash Flow

-$31M

Free Cash Flow

-$34M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$292M

Total Liabilities

$2.9B

Stockholders' Equity

-$2.6B

Cash & Equivalents

$31M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$121M	$81M	+49.9%
Gross Profit	$57M	$26M	+118.5%
Operating Income	-$58M	-$92M	+37.2%
Net Income	-$103M	-$111M	+7.6%